Skip to content

Usefulness of the HIV-antigen/antibody detecting screening test kit by using dried blood spot samples

Usefulness of the HIV-antigen/antibody detecting screening test kit by using dried blood spot samples - DBS study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044865
Enrollment
200
Registered
2021-07-15
Start date
2021-07-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection

Interventions

None listed

Sponsors

National Center for Global Health and Medicine
Lead Sponsor
FUJIREBIO Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Age of 20 years or older person who have obtained written consent in the study. (2)Person who diagnosed HIV infection and non-HIV infection

Exclusion criteria

Exclusion criteria: (1)Person whose physicians consider the study enrollment inappropriate.

Design outcomes

Primary

MeasureTime frame
To examine sensitivity and specificity of Lumiplus test by using dried blood spot samples

Secondary

MeasureTime frame
To determine the cut off value of Lumiplus test by using dried blood spot samples

Countries

Japan

Contacts

Public ContactShinichi Oka

National Center for Global Health and Medicine AIDS Clinical Center

oka@acc.ncgm.go.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026